• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Celgene Corporation (CELG)

    -NasdaqGS
    123.89 0.18(0.15%) Jan 23, 4:00PM EST
    |Pre-Market : 124.48 Up 0.58 (0.47%) 8:35AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:123.71
    Open:123.87
    Bid:123.95 x 200
    Ask:124.49 x 100
    1y Target Est:125.17
    Beta:2.02
    Next Earnings Date:29-Jan-15CELG Earnings announcement
    Day's Range:122.36 - 124.38
    52wk Range:66.85 - 124.38
    Volume:3,510,721
    Avg Vol (3m):5,283,530
    Market Cap:98.95B
    P/E (ttm):64.90
    EPS (ttm):1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 0.15%98.95B
    JNJ286.07B

    Key Statistics

    Forward P/E (1 yr):25.39
    P/S (ttm):13.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.69
    Quarterly EPS Est (Dec-14) :0.99
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):1.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback